Quick answer: Sometimes. Whether Cigna covers weight loss medication depends entirely on your specific plan, not on Cigna as a company. Many employer and commercial Cigna plans cover FDA-approved GLP-1 drugs like Wegovy (semaglutide) and Zepbound (tirzepatide) for obesity, but almost always with prior authorization, a BMI requirement (usually 30, or 27 with a condition like high blood pressure or sleep apnea), and step therapy. A large and growing share of plans exclude anti-obesity drugs entirely, and Ozempic and Mounjaro are only covered for type 2 diabetes, not for weight loss. The only way to know for sure is to read your formulary or call the number on your card.
This is the single most confusing question in the GLP-1 world, and the honest answer frustrates people: “Cigna” does not decide. Your employer or your individual plan does. Two coworkers with Cigna cards can get completely different answers because their companies bought different drug benefits. Below is exactly how the coverage actually works, which drugs fall where, what prior authorization really demands, and what to do when the answer is no.
Does Cigna cover GLP-1 for weight loss?
Many Cigna plans do cover GLP-1 medication for weight loss, but coverage is conditional and far from guaranteed. Cigna’s pharmacy benefit is administered through Express Scripts and its specialty arm, and anti-obesity drugs sit on a tier that almost always requires prior authorization (PA). When a plan covers them, you typically need to meet criteria that mirror the FDA labels and clinical guidelines.
Common requirements across covered Cigna plans include:
- A BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea.
- Documentation that you have tried lifestyle changes (reduced-calorie diet and increased activity) for several months.
- Enrollment in or willingness to follow a lifestyle modification program.
- Sometimes step therapy, meaning you must try a cheaper option first before the plan approves the newer drug.
The catch most people miss: weight loss drug coverage is an optional rider that employers can add or drop at renewal. Because GLP-1 spending has exploded, a rising number of employers have chosen to exclude obesity drugs while keeping diabetes coverage intact. So your plan may cover Ozempic for a diabetic colleague and refuse Wegovy for you, even though they share an active ingredient.
How do you actually check if your Cigna plan covers it?
Because coverage lives in your specific plan and not in “Cigna” as a brand, the fastest way to stop guessing is to look at three sources yourself before your doctor writes anything. Do these in order and you will usually have a clear yes or no in under half an hour.
- Log in to myCigna and pull your drug list. Use the price-a-medication or drug-cost tool and search the exact brand you want, Wegovy or Zepbound, not the diabetes name. If it shows a covered tier and a copay, the drug is on your formulary. If it says “not covered” or “excluded,” that is your answer for that specific plan.
- Call the member services number on the back of your card. Ask three precise questions: Does my plan include anti-obesity or weight loss drug coverage at all? Is Wegovy (or Zepbound) on my formulary, and on what tier? What are the prior authorization criteria? The word “exclusion” is the one you are listening for, because no paperwork overrides a benefit exclusion.
- Ask your employer’s benefits or HR contact. Weight loss drug coverage is often an optional rider the employer chooses to buy or drop at renewal, so HR frequently knows whether the obesity benefit was purchased this plan year before member services can confirm it.
Write down the exact answers, including the PA criteria, before your clinic starts a request. The most common reason a weight loss drug request drags on for weeks is that nobody confirmed coverage existed in the first place, and the office ends up filing a prior authorization against a benefit that was never in the plan.
What weight loss medications does Cigna cover?
When a Cigna plan includes anti-obesity drug coverage, the medications most likely to be on the formulary are the FDA-approved weight loss drugs, not the diabetes versions used off-label. Here is how the major drugs break down by what they are approved for and how Cigna generally treats them.
| Drug (active ingredient) | FDA-approved for | Typical Cigna stance for weight loss |
|---|---|---|
| Wegovy (semaglutide) | Chronic weight management | Often covered with prior authorization on plans that include obesity benefits |
| Zepbound (tirzepatide) | Chronic weight management, also sleep apnea with obesity | Often covered with prior authorization on plans that include obesity benefits |
| Saxenda (liraglutide) | Chronic weight management | Sometimes covered, often as a step-therapy option, older daily injection |
| Ozempic (semaglutide) | Type 2 diabetes only | Not covered for weight loss, covered for diabetes |
| Mounjaro (tirzepatide) | Type 2 diabetes only | Not covered for weight loss, covered for diabetes |
| Contrave, Qsymia (pills) | Chronic weight management | Sometimes covered, cheaper, occasionally required as step therapy first |
The pattern that runs through that whole table: Cigna covers a drug for the use the FDA approved it for. Wegovy and Zepbound are the weight loss molecules. Ozempic and Mounjaro are the exact same molecules sold under diabetes labels, and insurers will not pay for them for weight loss because that is an off-label use. A doctor can still prescribe Ozempic off-label, but you will almost certainly pay cash for it.
Will Cigna cover Wegovy for weight loss?
On plans that include anti-obesity drug coverage, Cigna will often cover Wegovy after prior authorization. Wegovy is the FDA-approved version of semaglutide for chronic weight management, so it is the legitimate target when you want semaglutide covered for weight loss rather than diabetes.
In the STEP trials, the registration studies for Wegovy, adults without diabetes lost roughly 15 percent of their body weight on average over about 68 weeks at the full 2.4 mg dose, paired with diet and activity. That is the kind of result that gets a drug approved and gets payers to consider covering it. To get a Wegovy PA approved through Cigna, your clinician usually has to submit your BMI, any weight-related conditions, and a record of prior lifestyle efforts. If your plan simply excludes weight loss drugs, no amount of paperwork will change the answer, and that is the first thing to confirm before your doctor spends time on a PA.
Will Cigna cover Zepbound for weight loss?
Zepbound is treated much like Wegovy: often covered with prior authorization on plans that include obesity benefits, and excluded entirely on plans that dropped the rider. Zepbound is tirzepatide approved for chronic weight management, and in 2025 it also gained FDA approval for moderate to severe obstructive sleep apnea in adults with obesity, which gives some patients a second medical reason that can support a PA.
Zepbound tends to produce the largest average weight loss of the current injectables. In the SURMOUNT trials, adults without diabetes lost on average more than 20 percent of body weight at the higher tirzepatide doses over roughly 72 weeks. Because it works on two gut hormone pathways (GLP-1 and GIP) rather than one, many clinicians reach for it first when a plan covers it. If Cigna covers only one of the two, your prescriber may steer toward whichever the formulary actually pays for, since the out-of-pocket gap between covered and not covered is enormous.
Does Cigna cover Ozempic and Mounjaro for weight loss?
No. Cigna does not cover Ozempic or Mounjaro for weight loss, because neither drug is FDA-approved for weight loss. Both are approved for type 2 diabetes, and Cigna covers them for that diagnosis (again, usually with prior authorization tied to a diabetes diagnosis and lab evidence such as an A1C).
This trips up a lot of people because Ozempic became famous as a weight loss drug. The reality is mechanical: Ozempic is semaglutide and Mounjaro is tirzepatide, the very same active ingredients as Wegovy and Zepbound. The manufacturer chose to sell the weight loss versions under different names at higher list prices. Insurers, including Cigna, will not pay for the diabetes drug just because you want the weight loss effect. If your prescriber writes Ozempic for weight loss, expect a denial or a cash price that often lands around $900 to $1,000 a month at retail. The covered path for weight loss runs through Wegovy or Zepbound, not their diabetes twins. Curious how the injectables stack up against each other? Here is a deeper look at what is the best injection for weight loss.
What does prior authorization actually require, and what stalls people?
Prior authorization is where most Cigna weight loss drug requests die, and almost always for avoidable reasons. A PA is your clinician asking Cigna to confirm you meet the coverage rules before the pharmacy fills the script. The decision usually comes back in a few business days. Here is what typically has to be on the form, and the mistakes that get people denied.
- BMI not documented correctly. The chart needs a current, recorded BMI that clears the threshold (30, or 27 with a comorbidity). A vague “patient is overweight” note is not enough.
- No record of prior lifestyle effort. Many plans want documentation that you tried diet and exercise for a stretch (often three to six months) before approving a drug. If your chart is silent on this, the PA stalls.
- Skipping step therapy. Some plans require you to try a cheaper drug, such as Contrave or Qsymia, or to fail it, before they approve a GLP-1.
- Wrong drug for the diagnosis. Requesting Ozempic for weight loss is an automatic denial. The PA has to match the FDA-approved use.
- The plan simply excludes obesity drugs. This is the big one. No PA can override a benefit exclusion. Confirm coverage exists before anyone fills out a form.
One more thing people get wrong: assuming a denial is final. Cigna PAs can be appealed, and a strong appeal that adds missing documentation (comorbidities, prior attempts, why alternatives are unsuitable) overturns a meaningful share of initial denials. Your prescriber’s office handles this, so push them to appeal rather than walking away.
What a strong prior authorization packet looks like
The requests that clear on the first try tend to look the same. They include a current, charted BMI that clears the threshold, the specific weight-related conditions with their diagnosis codes (type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, fatty liver), and dated notes showing a real lifestyle attempt rather than a single line saying “advised diet.” If your plan uses step therapy, the packet should also show which cheaper option you tried and why it failed or was not tolerated. When your clinician has all of that in the chart before submitting, the whole thing moves faster, and if a denial comes back, most of the appeal is already written.
A quick, realistic example. Someone with a BMI of 34, high blood pressure, and a six-month record of a supervised diet gets Wegovy approved on the first PA because the chart answers every question the reviewer asks. A coworker on the same employer plan, BMI 31, no documented comorbidity, and no lifestyle notes, gets denied, not because the plan is different, but because the paperwork was thin. The difference is almost never the drug. It is the documentation.
No coverage? Get a real clinician, not the gray market.
Joi + Blokes is a telehealth clinic that prescribes GLP-1 medication (Zepbound, compounded semaglutide and tirzepatide), hormone therapy, thyroid care and peptides after a real lab panel and clinician review, with no membership or consult fee (prescriptions from about $59/month, hormone and GLP-1 lab panels from $149). If Cigna excludes weight loss drugs or your PA gets denied, this is a supervised, legitimate cash route that beats sketchy online sellers. Here is Joi + Blokes reviewed in full.
What does it cost if Cigna does not cover it?
If your Cigna plan excludes weight loss drugs or denies your PA, your out-of-pocket cost depends heavily on the route you take, and the spread is wide. Here is the realistic 2026 landscape for someone paying cash.
| Route | Typical monthly cost | Notes |
|---|---|---|
| Brand Wegovy or Zepbound, retail cash, no coverage | About $1,000 to $1,350 list | Manufacturer self-pay programs can lower this for certain doses |
| Manufacturer direct self-pay (single-dose vials) | Often $349 to $499 | Available directly from the drugmaker for cash patients on some doses |
| Compounded semaglutide via telehealth | Often $150 to $300 | Not FDA-approved, legally prescribed by licensed clinicians and pharmacies |
| Compounded tirzepatide via telehealth | Often $200 to $400 | Not FDA-approved, prescribed and supervised by a clinician |
| Older pills (Contrave, Qsymia) | Often $100 or less with coupons | Less effective on average than GLP-1 injections |
Be precise about one distinction the marketing blurs: brand Wegovy and Zepbound are FDA-approved. Compounded semaglutide and tirzepatide are not FDA-approved drugs. They are legally prescribed through licensed clinicians and compounding pharmacies, and a supervised telehealth program is a reasonable cash option, but you should never buy “semaglutide” from an unlicensed website, a social media seller, or a research-peptide shop. That is where people get under-dosed, over-dosed, or sold something that is not what the label claims. If you are paying cash, do it through a clinician who runs labs and follows you.
Does Cigna cover weight loss surgery?
Many Cigna plans do cover bariatric (weight loss) surgery, and the criteria are usually stricter and more documented than for drugs. Typical requirements include a BMI of 40 or higher, or 35 or higher with a serious weight-related condition, a documented history of failed medically supervised weight loss attempts, a psychological evaluation, and a supervised pre-surgical program that can run several months. Procedures often covered include sleeve gastrectomy and gastric bypass.
As with drugs, surgery coverage is plan-specific and frequently requires prior authorization. Some employer plans exclude bariatric surgery entirely. If surgery is on your radar, ask your plan directly whether bariatric benefits are included before you start the multi-month workup, because the supervised program is a significant time investment to discover at the end that the benefit was never there.
The honest take: stop guessing, start with your numbers
The reason so many people churn through denials, gray-market vials, and yo-yo results is that they are guessing instead of measuring. A GLP-1 is a powerful tool, but it is not a diagnosis. If the scale will not move, the cause is often something a lab can flag: an underactive thyroid, insulin resistance, low testosterone in men, or perimenopausal hormone shifts in women. These are exactly the conditions that both justify a stronger insurance case (comorbidities help your PA) and change which treatment makes sense.
If your Cigna coverage is a dead end, the smart move is not to chase the cheapest peptide online. It is to work with a clinician who runs the right labs, prescribes the right medication at the right dose, and tracks you. That is the difference between a supervised program and a guess. If you want to see your full metabolic and hormone picture first, here is how a full-body blood panel works. And before you start or stop any of these medications, talk to a clinician, because how you come off a GLP-1 matters as much as how you start.
The markers worth having in hand are not exotic. A thyroid panel (TSH, and free T4 if TSH is off) tells you whether an underactive thyroid is quietly slowing everything down. Fasting glucose and A1C, ideally with a fasting insulin, show whether insulin resistance is the engine behind the weight, which is exactly the pattern GLP-1 drugs are built to address. In men, a low testosterone reading can explain stubborn central fat and low energy; in women, the timing of perimenopause reshapes where weight lands and how easily it comes off. None of these numbers replace a GLP-1, but each one either strengthens your insurance case or changes the plan. A documented comorbidity is often the same lab result that turns a thin prior authorization into an approved one, so pulling your numbers is not just clinically smart, it can be the thing that gets the drug covered.
Test the markers behind the scale, not just the scale
Superpower is a full-body lab membership that runs 100+ biomarkers, including thyroid, fasting insulin, A1C, and hormones, has each result reviewed by a doctor, and tracks your numbers year over year (about $199/year). It is the clean way to see whether thyroid, insulin, or hormones are the real reason the scale will not move, and the same results can strengthen a prior authorization. Here is Superpower reviewed in full.
FAQ
Does Cigna insurance cover weight loss medication for everyone?
No. Coverage depends on your specific plan, not on Cigna as a company. Some plans cover FDA-approved weight loss drugs with prior authorization, while a growing number of employer plans exclude obesity medications entirely. Check your formulary or call the number on your card.
Does Cigna cover semaglutide for weight loss?
Cigna may cover semaglutide for weight loss when it is prescribed as Wegovy, the FDA-approved weight management version, on a plan that includes obesity coverage and after prior authorization. It will not cover Ozempic (the diabetes version of semaglutide) for weight loss.
Does Cigna cover tirzepatide for weight loss?
Cigna may cover tirzepatide for weight loss when it is prescribed as Zepbound, the FDA-approved weight management version, on plans with obesity coverage and after prior authorization. Mounjaro, the diabetes version of tirzepatide, is not covered for weight loss.
Does Cigna cover weight loss injections without a diabetes diagnosis?
Yes, on plans that include anti-obesity coverage. Wegovy and Zepbound are approved for weight management in people without diabetes, so you do not need a diabetes diagnosis. You generally need to meet the BMI threshold and complete prior authorization.
How long does Cigna prior authorization for a GLP-1 take?
A standard prior authorization decision usually comes back within a few business days once your clinician submits the request with your BMI, comorbidities, and prior lifestyle efforts. Missing documentation is the most common cause of delay or denial.
What if Cigna denies my weight loss medication?
You can appeal. Many initial denials are overturned when the appeal adds documentation the first request lacked, such as weight-related conditions or records of prior diet and exercise attempts. Ask your prescriber’s office to file the appeal rather than giving up.
Will Cigna keep covering my GLP-1 long term?
Coverage can change at plan renewal, and many employers have tightened or dropped obesity drug benefits as costs rose. Even when covered, plans may require periodic reauthorization showing you are still meeting weight loss goals. For more on duration, see how long do you take Wegovy for weight loss.
Is Mounjaro approved for weight loss?
No. Mounjaro is FDA-approved for type 2 diabetes only. The same drug, tirzepatide, is approved for weight loss under the name Zepbound. For the full breakdown, see is Mounjaro approved for weight loss.
How do I get Ozempic if Cigna will not cover it for weight loss?
For weight loss, the better route is the FDA-approved drug (Wegovy or Zepbound) rather than off-label Ozempic. If you still want semaglutide, a supervised telehealth clinician can prescribe an appropriate option. Here is more on how to get Ozempic for weight loss.
Do other insurers cover these drugs the same way?
The structure is similar across major insurers: FDA-approved weight loss drugs are often covered with prior authorization, diabetes versions are not covered for weight loss, and obesity benefits are increasingly optional. For a side-by-side, see whether Blue Cross Blue Shield covers weight loss injections.
What BMI do I need for Cigna to cover weight loss medication?
On plans that include obesity coverage, the usual threshold mirrors the FDA labels: a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea. Bariatric surgery criteria are stricter, typically a BMI of 40, or 35 with a serious condition. Your exact plan may vary, so confirm the number in your plan’s coverage policy.
Does Cigna cover compounded semaglutide or tirzepatide?
Generally no. Insurance, including Cigna, covers FDA-approved brand drugs, and compounded semaglutide and tirzepatide are not FDA-approved products, so they are almost always a cash route rather than a covered benefit. Availability of compounded versions has also tightened, so if you go this way, do it only through a licensed clinician and pharmacy that runs labs and supervises you, never an unlicensed website.
Can I use a manufacturer savings card with my Cigna plan?
Sometimes, if you have commercial Cigna coverage and the drug is covered, a manufacturer copay card may lower your share for eligible doses. These cards typically cannot be combined with government insurance such as Medicare or Medicaid. If your plan excludes the drug, the more relevant option is usually the manufacturer’s cash self-pay program rather than a copay card. Check the drugmaker’s site for current terms.
Does Cigna Medicare cover weight loss drugs?
Medicare has long excluded drugs used specifically for weight loss by statute, so a Medicare plan generally will not cover a GLP-1 for obesity alone. Coverage can exist when the same drug is prescribed for a separate approved indication, such as type 2 diabetes or an approved cardiovascular use, which is a different diagnosis. Check your specific Medicare plan’s drug list and talk to your prescriber about which indication applies to you.
